Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aisen

Showing results (31-40 of 981) with videos related to

Pageof 99
Sort By:
Nature Clinical Practice. Neurology|August 26, 2006
Can rofecoxib delay a diagnosis of Alzheimer's disease in patients with mild cognitive impairment?Paul S Aisen
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 18, 2011
Commentary on "Biomarkers in Alzheimer's disease drug development." Can't live without 'emPaul S Aisen
JAMA|April 24, 2014
Serum brain-derived neurotrophic factor and the risk for dementiaPaul S Aisen
The Journal of Prevention of Alzheimer'S Disease|May 8, 2019
Editorial: Failure After Failure. What Next in AD Drug Development?P S Aisen
Journal of Rehabilitation Research and Development|February 5, 2000
Enabling veterans: the challenge and the promise of the next milleniumM L Aisen
Neurobiology of Aging|October 11, 2011
Clinical trial methodologies for disease-modifying therapeutic approachesPaul S Aisen
Alzheimer'S Research & Therapy|August 14, 2009
Alzheimer's disease therapeutic research: the path forwardPaul S Aisen
Acta Neurologica Scandinavica. Supplementum|March 23, 2001
Anti-inflammatory therapy for Alzheimer's disease: implications of the prednisone trialP S Aisen
The Journal of Nutrition, Health & Aging|March 23, 2010
Pre-dementia Alzheimer's trials: overviewP S Aisen
Neurology|January 28, 1999
Justifying neurorehabilitation: a few steps forwardM L Aisen
Pageof 99

Showing results (31-40 of 981) with videos related to

Sort By:
Pageof 99
Nature Clinical Practice. Neurology|August 26, 2006
Can rofecoxib delay a diagnosis of Alzheimer's disease in patients with mild cognitive impairment?Paul S Aisen
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 18, 2011
Commentary on "Biomarkers in Alzheimer's disease drug development." Can't live without 'emPaul S Aisen
JAMA|April 24, 2014
Serum brain-derived neurotrophic factor and the risk for dementiaPaul S Aisen
The Journal of Prevention of Alzheimer'S Disease|May 8, 2019
Editorial: Failure After Failure. What Next in AD Drug Development?P S Aisen
Journal of Rehabilitation Research and Development|February 5, 2000
Enabling veterans: the challenge and the promise of the next milleniumM L Aisen
Neurobiology of Aging|October 11, 2011
Clinical trial methodologies for disease-modifying therapeutic approachesPaul S Aisen
Alzheimer'S Research & Therapy|August 14, 2009
Alzheimer's disease therapeutic research: the path forwardPaul S Aisen
Acta Neurologica Scandinavica. Supplementum|March 23, 2001
Anti-inflammatory therapy for Alzheimer's disease: implications of the prednisone trialP S Aisen
The Journal of Nutrition, Health & Aging|March 23, 2010
Pre-dementia Alzheimer's trials: overviewP S Aisen
Neurology|January 28, 1999
Justifying neurorehabilitation: a few steps forwardM L Aisen
Pageof 99